The skin is the biggest organ of the human being and has many functions. Therefore, the healing of a skin wound displays an extraordinary mechanism of cascading cellular functions which is unique in nature. As healing and regeneration processes take place in all parts of the human body, this review focuses on the healing processes of the skin and highlights the classical wound healing phases. While regeneration describes the specific substitution of the tissue, i.e. the superficial epidermis, mucosa or fetal skin, skin repair displays an unspecific form of healing in which the wound heals by fibrosis and scar formation. The first stage of acute wound healing is dedicated to hemostasis and the formation of a provisional wound matrix, which occurs immediately after injury and is completed after some hours. Furthermore, this phase initiates the inflammatory process. The inflammatory phase of the wound healing cascade gets activated during the coagulation phase and can roughly be divided into an early phase with neutrophil recruitment and a late phase with the appearance and transformation of monocytes. In the phase of proliferation the main focus of the healing process lies in the recovering of the wound surface, the formation of granulation tissue and the restoration of the vascular network. Therefore, next to the immigration of local fibroblasts along the fibrin network and the beginning of reepithelialization from the wound edges, neovascularization and angiogenesis get activated by capillary sprouting. The formation of granulation tissue stops through apoptosis of the cells, characterizing a mature wound as avascular as well as acellular. During the maturation of the wound the components of the extracellular matrix undergo certain changes. The physiological endpoint of mammalian wound repair displays the formation of a scar, which is directly linked to the extent of the inflammatory process throughout wound healing.

Keywords:
Angiogenesis, Epithelialization, Granulation tissue, Inflammation, Scarring
1.
Robson MC, Steed DL, Franz MG: Wound healing: biologic features and approaches to maximize healing trajectories. Curr Probl Surg 2001;38:72–140.
2.
Lazarus GS, Cooper DM, Knighton DR, Percoraro RE, Rodeheaver G, Robson MC: Definitions and guidelines for assessment of wounds and evaluation of healing. Wound Repair Regen 1994;2:165–170.
3.
Krafts KP: Tissue repair: the hidden drama. Organogenesis 2010;6:225–233.
4.
Enoch S, John Leaper D: Basic science of wound healing. Surgery (Oxford) 2005;23:37–42.
5.
Eming SA, Krieg T, Davidson JM: Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol 2007;127:514–525.
6.
Epstein HF: Cutaneous wound healing. N Engl J Med 1999;341:738–746.
7.
Strodtbeck F: Physiology of wound healing. Newborn Infant Nurs Rev 2001;1:43–52.
8.
Martin P: Wound healing – aiming for perfect skin regeneration. Science 1997;276:75–81.
9.
Woo YC, Park SS, Subieta AR, Brennan TJ: Changes in tissue pH and temperature after incision indicate acidosis may contribute to postoperative pain. Anesthesiology 2004;101:468–475.
10.
Werner S, Grose R: Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835–870.
11.
Daley JM, Reichner JS, Mahoney EJ, Manfield L, Henry WL, Mastrofrancesco B, et al: Modulation of macrophage phenotype by soluble product(s) released from neutrophils. J Immunol 2005;174:2265–2272.
12.
Tziotzios C, Profyris C, Sterling J: Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics. J Am Acad Dermatol 2012;66:13–24.
13.
Profyris C, Tziotzios C, Do Vale I: Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics. J Am Acad Dermatol 2012;66:1–10.
14.
Gurtner GC, Werner S, Barrandon Y, Longaker MT: Wound repair and regeneration. Nature 2008;453:314–321.
15.
Leibovich SJ, Ross R: The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am J Pathol 1975;78:71–100.
16.
Bullard KM, Longaker MT, Lorenz HP: Fetal wound healing: current biology. World J Surg 2003;27:54–61.
17.
Redd MJ, Cooper L, Wood W, Stramer B, Martin P: Wound healing and inflammation: embryos reveal the way to perfect repair. Philos Trans R Soc Lond B Biol Sci 2004;359:777–784.
18.
Koh TJ, DiPietro LA: Inflammation and wound healing: the role of the macrophage. Expert Rev Mol Med 2011;13:e23.
19.
DiPietro LA, Polverini PJ: Role of the macrophage in the positive and negative regulation of wound neovascularization. Behring Inst Mitt 1993;92:238–247.
20.
Bauer SM: Angiogenesis, vasculogenesis, and induction of healing in chronic wounds. Vasc Endovasc Surg 2005;39:293–306.
21.
Arnold F, West DC: Angiogenesis in wound healing. Pharmacol Ther 1991;52:407–422.
22.
Endrich B, Menger MD: Regeneration of the microcirculation during wound healing? Unfallchirurg 2000;103:1006–1008.
23.
Madden JW, Peacock EE: Studies on the biology of collagen during wound healing. 3. Dynamic metabolism of scar collagen and remodeling of dermal wounds. Ann Surg 1971;174:511–520.
24.
Lau K, Paus R, Tiede S, Day P, Bayat A: Exploring the role of stem cells in cutaneous wound healing. Exp Dermatol 2009;18:921–933.
25.
Miller SJ, Burke EM, Rader MD, Coulombe PA, Lavker RM: Re-epithelialization of porcine skin by the sweat apparatus. J Invest Dermatol 1998;110:13–19.
26.
Roh C, Lyle S: Cutaneous stem cells and wound healing. Pediatr Res 2006;59:100R–103R.
27.
Jacinto A, Martinez-Arias A, Martin P: Mechanisms of epithelial fusion and repair. Nat Cell Biol 2001;3:E117–E123.
28.
Clark RA, Lanigan JM, DellaPelle P, Manseau E, Dvorak HF, Colvin RB: Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982;79:264–269.
29.
Clark RA: Fibronectin in the skin. J Invest Dermatol 1981;6:475–479.
30.
Nobes CD, Hall A: Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 1999;144:1235–1244.
31.
Nobes CD, Hall A: Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell 1995;81:53–62.
32.
Sorg H, Krueger C, Vollmar B: Intravital insights in skin wound healing using the mouse dorsal skin fold chamber. J Anat 2007;211:810–818.
33.
Nauta A, Gurtner G, Longaker M: Wound healing and regenerative strategies. Oral Dis 2011 18;17:541–549.
34.
Eckes B, Nischt R, Krieg T: Cell-matrix interactions in dermal repair and scarring. Fibrogenesis Tissue Repair 2010;3:4.
35.
Barker TH: The role of ECM proteins and protein fragments in guiding cell behavior in regenerative medicine. Biomaterials 2011;32:4211–4214.
36.
Hinz B: Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007;127:526–537.
37.
Greenhalgh DG: The role of apoptosis in wound healing. Int J Biochem Cell Biol 1998;30:1019–1030.
38.
Gurtner GC, Evans GRD: Advances in head and neck reconstruction. Plast Reconstr Surg 2000;106:672–682.
39.
Rowlatt U: Intrauterine wound healing in a 20 week human fetus. Virchows Arch A Pathol Anat Histol 1979;381:353–361.
40.
Whitby DJ, Ferguson MW: The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development 1991;112:651–668.
41.
Ferguson MW, O’Kane S: Scar-free healing: from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc B Biol Sci 2004;359:839–850.
42.
Colwell AS, Krummel TM, Longaker MT, Lorenz HP: An in vivo mouse excisional wound model of scarless healing. Plast Reconstr Surg 2006;117:2292–2296.
43.
Somasundaram K, Prathap K: Intra-uterine healing of skin wounds in rabbit foetuses. J Pathol 1970;100:81–86.
44.
Cass DL, Bullard KM, Sylvester KG, Yang EY, Longaker MT, Adzick NS: Wound size and gestational age modulate scar formation in fetal wound repair. J Pediatr Surg 1997;32:411–415.
45.
Lorenz HP, Whitby DJ, Longaker MT, Adzick NS: Fetal wound healing. The ontogeny of scar formation in the non-human primate. Ann Surg 1993;217:391–396.
46.
Lorenz HP, Lin RY, Longaker MT, Whitby DJ, Adzick NS: The fetal fibroblast: the effector cell of scarless fetal skin repair. Plast Reconstr Surg 1995;96:1251–1261.
47.
Coolen N, Schouten K, Middelkoop E, Ulrich MM: Comparison between human fetal and adult skin. Arch Dermatol Res 2010;302:47–55.
48.
Lane A: Human fetal skin development. Pediatr Dermatol 1986;3:487–491.
49.
Whitby DJ, Ferguson MW: Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol 1991;147:207–215.
50.
Beanes SR, Hu F-Y, Soo C, Dang CMH, Urata M, Ting K, et al: Confocal microscopic analysis of scarless repair in the fetal rat: defining the transition. Plast Reconstr Surg 2002;109:160–170.
51.
Rendl M, Lewis L, Fuchs E: Molecular dissection of mesenchymal-epithelial interactions in the hair follicle. PLoS Biol 2005;3:e331.
52.
Soo C, Hu FY, Zhang X, Wang Y, Beanes SR, Lorenz HP, et al: Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. Am J Pathol 2000;157:423–433.
53.
Beanes SR, Dang C, Soo C, Wang Y, Urata M, Ting K, et al: Down-regulation of decorin, a transforming growth factor-beta modulator, is associated with scarless fetal wound healing. J Ped Surg 2001;36:1666–1671.
54.
Wagers AJ, Christensen JL, Weissman IL: Cell fate determination from stem cells. Gene Ther 2002;9:606–612.
55.
Shizuru JA, Negrin RS, Weissman IL: Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med 2005;56:509–538.
56.
Cowin AJ, Brosnan MP, Holmes TM, Ferguson MW: Endogenous inflammatory response to dermal wound healing in the fetal and adult mouse. Dev Dyn 1998;212:385–393.
57.
O’Kane S, Ferguson MW: Transforming growth factor beta s and wound healing. Int J Biochem Cell Biol 1997;29:63–78.
58.
Ashcroft G, Mills S, Lei K, Gibbons L, Jeong MJ, Taniguchi M, et al: Estrogen modulates cutaneous wound healing by downregulating macrophage migration inhibitory factor. J Clin Invest 2003;111:1309–1318.
59.
Ashcroft GS, Yang X, Glick AB, Weinstein M, Letterio JL, Mizel DE, et al: Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1999;1:260–266.
60.
Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E: Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 1998;111:850–857.
61.
Ehrlich HP, Desmoulière A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, et al: Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 1994;145:105–113.
62.
Verhaegen PD, van Zuijlen PP, Pennings NM, van Marle J, Niessen FB, van der Horst CM, Middelkoop E: Differences in collagen architecture between keloid, hypertrophic scar, normotrophic scar, and normal skin: an objective histopathological analysis. Wound Repair Regen 2009;17:649–656.
63.
Xi-Qiao W, Ying-Kai L, Chun Q, Shu-Liang L: Hyperactivity of fibroblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring. Microvasc Res 2009;77:204–211.
64.
Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, Loh SA, et al: Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J 2007;21:3250–3261.
65.
Darby IA, Bisucci T, Pittet B, Garbin S, Gabbiani G, Desmoulière A: Skin flap-induced regression of granulation tissue correlates with reduced growth factor and increased metalloproteinase expression. J Pathol 2002;197:117–127.
66.
Bellemare J, Roberge C, Bergeron D, Lopez-Valle CA, Roy M, Moulin VJ: Epidermis promotes dermal fibrosis: role in the pathogenesis of hypertrophic scars. J Pathol 2005;206:1–8.
67.
Dabiri G, Tumbarello DA, Turner CE, Van de Water L: Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-beta1 autocrine loop. J Invest Dermatol 2008;128:2518–2525.
68.
Akaishi S, Ogawa R, Hyakusoku H: Keloid and hypertrophic scar: neurogenic inflammation hypotheses. Med Hypotheses 2008;71:32–38.
69.
Sarrazy V, Billet F, Micallef L, Coulomb B, Desmoulière A: Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen 2011;19:s10–s15.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.